Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
90 studies found for:    topeka | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
Condition: Celiac Disease
Interventions: Drug: ALV003;   Drug: placebo
22 Recruiting A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: MEDI4736;   Other: PLACEBO
23 Recruiting A Study of Lebrikizumab in Patients With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication
Condition: Asthma
Interventions: Drug: lebrikizumab;   Drug: placebo
24 Recruiting SYMPHONY: A Study of Macitentan in Pulmonary Arterial Hypertension to Validate the PAH-SYMPACT
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Macitentan
25 Recruiting The Safety And Efficacy Of Maintenance Therapy With CP-690,550
Condition: Crohn's Disease
Interventions: Drug: Placebo;   Drug: CP-690,550
26 Recruiting Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: RHB-104;   Drug: Placebo
27 Recruiting Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Condition: Venous Thromboembolism (VTE)
Interventions: Drug: Betrixaban;   Drug: Enoxaparin
28 Recruiting Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
Condition: Hormone Receptor Positive Breast Cancer
Interventions: Drug: Everolimus;   Drug: Letrozole;   Drug: Exemestane;   Drug: Alcohol-free dexamethasone mouth rinse
29 Recruiting Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
Conditions: Severe Sepsis;   Coagulopathy
Interventions: Drug: ART-123;   Drug: Placebo
30 Recruiting A Study of LY2835219 in Participants With Previously Treated Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: LY2835219;   Drug: Erlotinib
31 Recruiting A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: tofacitinib;   Drug: Placebo
32 Recruiting Trial to Compare the Efficacy and Safety of NNC0195-0092 With Placebo and Norditropin® FlexPro® in Adults With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Adult Growth Hormone Deficiency
Interventions: Drug: NNC0195-0092;   Drug: somatropin;   Drug: placebo
33 Recruiting Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Carcinoma
Interventions: Biological: TG4010;   Drug: placebo
34 Recruiting An Efficacy and Safety Trial of MK-8931 in Mild to Moderate Alzheimer's Disease (P07738)
Condition: Alzheimer's Disease
Interventions: Drug: MK-8931 (Part I and Part II);   Drug: Placebo (Part I);   Drug: MK-8931 (Part II)
35 Available Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Panobinostat
36 Recruiting Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Condition: Lung Cancer
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Drug: cisplatin;   Drug: etoposide
37 Recruiting Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: CP-690,550
38 Recruiting Randomized On-X Anticoagulation Trial
Condition: Heart Valve Disease
Interventions: Device: On-X valve using reduced anticoagulation;   Device: On-X Valve with Standard Coumadin Therapy
39 Available Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
Condition: Non-small Cell Lung Cancer (NSCLC)
Intervention: Drug: LDK378
40 Recruiting Nintedanib (BIBF 1120) vs Placebo in Refractory Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: Nindetanib (BIBF 1120);   Drug: Placebo;   Drug: BSC

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years